drugset / Trial / NCT00325182

The Effects of Levetiracetam on Alcohol Dependent Subjects

NCT00325182

Phase 4 Completed 40 enrolled Boston University UCB Pharma · collab
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study will attempt to examine whether Levetiracetam (Keppra (TM)) can help people with alcohol dependence cut down on their alcohol consumption. In addition, the investigation will assess the effectiveness of Keppra on reducing withdrawal symptoms post alcohol cessation. Matched group of historical controls of alcohol dependent patients receiving placebo will be used for comparison.Based on the mechanism of action of Keppra we hypothesize that it may be effective in promoting abstinence and reducing drinking behavior in alcohol dependent patients.

Timeline

Start
2006-01
Primary completion
2007-01
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Levetiracetam Other / unclassified 1000 mg

Indications